Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
17 November 2014
Prosensa Announces 3rd Quarter 2014 Financial Results and Recent Corporate Developments
12 August 2014
Prosensa Announces 2nd Quarter 2014 Financial Results and Recent Corporate Developments
20 Mai 2014
Prosensa Announces 1st Quarter 2014 Financial Results and Recent Corporate Developments
18 März 2014
Prosensa Announces Full Year 2013 Financial Results and Recent Corporate Developments
13 Januar 2014
Prosensa Regains Rights to Drisapersen From GSK and Retains Rights to All Other Programs for the Treatment of Duchenne Muscular Dystrophy (DMD)
18 November 2013
Prosensa Announces Third Quarter 2013 Financial Results and Recent Corporate Developments
20 September 2013
GSK and Prosensa Announce Primary Endpoint Not Met in Phase III Study of Drisapersen in Patients With Duchenne Muscular Dystrophy
